Udaikumar, J.; Nimmagadda, R.; Lella, V.V.; Achuta, K.M.; Kuppili, S.; Avula, S.R.; Sarwar, R.
The Comparative Safety and Efficacy of Resmetirom and Semaglutide in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review. Pharmacoepidemiology 2025, 4, 14.
https://doi.org/10.3390/pharma4030014
AMA Style
Udaikumar J, Nimmagadda R, Lella VV, Achuta KM, Kuppili S, Avula SR, Sarwar R.
The Comparative Safety and Efficacy of Resmetirom and Semaglutide in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review. Pharmacoepidemiology. 2025; 4(3):14.
https://doi.org/10.3390/pharma4030014
Chicago/Turabian Style
Udaikumar, Jahnavi, Rithish Nimmagadda, Vindhya Vasini Lella, Kesava Manikanta Achuta, Satwik Kuppili, Suraj Reddy Avula, and Raiya Sarwar.
2025. "The Comparative Safety and Efficacy of Resmetirom and Semaglutide in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review" Pharmacoepidemiology 4, no. 3: 14.
https://doi.org/10.3390/pharma4030014
APA Style
Udaikumar, J., Nimmagadda, R., Lella, V. V., Achuta, K. M., Kuppili, S., Avula, S. R., & Sarwar, R.
(2025). The Comparative Safety and Efficacy of Resmetirom and Semaglutide in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review. Pharmacoepidemiology, 4(3), 14.
https://doi.org/10.3390/pharma4030014
